Very few individuals consult doctors for common conditions such as cold, cough, and allergies; most of them opt for OTC medicines instead. In view of such prominent practices, the global sales of the OTC cough, cold, and allergy medicines have remained propped up for the past decade or so.
Cough, cold, and allergy medicines are one of the most common OTC (over-the-counter) categories, however, physicians recommend their use only for minor health issues. In many countries, there are certain laws enforced on directs sales of these medicines in order to ensure consumer safety.
In addition, these medicines offer extreme convenience to a modern consumer, living a fast-paced life. The aforementioned factors are expected to reflect favorably on the global OTC cough, cold, and allergy medicines market over the next five years.
Moreover, an increasing number of immunosuppressed individuals and a rising global geriatric population is also expected to further drive the demand for OTC medicines for cough, cold, and allergy. The recent study conducted by Fact.MR reveals that the global OTC cough, cold, and allergy medicine market is poised to increase at a CAGR of 4.9% from 2017 to 2022 to reach a valuation of around US$ 37,300 Mn.
Asia-Pacific excluding Japan (APEJ) to Remain the Largest Market for OTC Cough, Cold and Allergy Medicines
Asia-Pacific excluding Japan (APEJ) is projected to remain the most lucrative market for OTC cough, cold, and allergy medicines throughout the forecast period. In terms of revenue, APEJ is anticipated to account for an impressive share of the global market in 2017 and beyond.
The region’s proximity to air pollution has led to the rise in the prevalence of various respiratory disorders. Moreover, the acceptance rate of OTC medicines is extremely high in the region owing to their low cost and convenience of purchase.
By drug type, the antihistamine is projected to account for more than one-third share of the market in terms of revenue by 2017-end.
Antihistamines drugs reduce the release of histamine from histamine-1 receptors and are commonly used for treating allergic reactions such as inflammation (redness), swelling (edema), watery eyes or runny nose, and sneezing.
Pharmacies will remain the leading OTC channel for sales of cough, cold, and allergy medicines during the assessment period. Meanwhile, the drug store OTC channel segment is expected to account for the second-largest revenue share of the market by 2017-end.
By dosage, the tablet segment is estimated to account for more than 33% revenue share of the market and is expected to reach a valuation of around US$ 12,400 Mn towards the end of the forecast period.
Know More Details About the Report
Key companies profiled in Fact.MR’s report include
- Johnson & Johnson Service Inc.
- Reckitt Benckiser Group Plc.
- Novartis AG
- GlaxoSmithKline Plc.
- AstraZaneca Plc.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Prestige Brands Holdings Inc.
- Procter & Gamble Co.
- Bristol-Myers Squib Co.
- Merck & Co.
Many of these market players are actively focusing on increasing their market presence and development of more efficient products.
Avail customized purchase options for your needs
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
The majority of OTC cough, cold, and allergy medicines manufacturers are actively focusing on raising the standards of functionality and effectiveness of their products.
Growing consumer awareness and the introduction of more effective anti-inflammatory drugs are facilitating the growth of the global OTC cough, cold, and allergy medicines market.
A recent report by Fact.MR provides an in-depth analysis of the global OTC cough, cold, and allergy medicine market for the forecast period 2017-2022, and offers pragmatic insights to lead market players towards devising & implementing informed strategies.
The scope of Fact.MR’s report is to analyze the global OTC cough, cold, and allergy medicines market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.
OTC cough, cold, and allergy medicine manufacturers, suppliers, and stakeholders in the global market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading magazines and journals pertaining to health and wellness.
The report commences with brief information on the global OTC cough, cold, and allergy medicines market. This executive summary sets the tone for the rest of the report, providing users the scope of the report.
The executive summary includes important facts and statistics on the global OTC cough, cold and allergy medicines market.
The next section offers an overview of the global OTC cough, cold and allergy medicines market. This comprises an introduction to the market, along with a standard definition of OTC cough, cold, and allergy medicines.
In this section, market value and year-over-year growth are offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints, and key trends from macroeconomic, demand, and supply perspectives.
Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global OTC cough, cold, and allergy medicines market, the report provides updates on market opportunities, which can benefit leading manufacturers of OTC cough, cold, and allergy medicines.
With the continuous evolution of the healthcare sector, keeping a record of the latest developments and trends is fundamental for OTC cough, cold and allergy medicines manufacturers to formulate key business strategies.
Detailed information on product sourcing, pricing analysis, cost structure, list of market players is provided in this section.
Considering the wide scope of the global OTC cough, cold and allergy medicines market and to offer in-depth insights, Fact.MR’s report provides segment-wise analysis and forecast.
The OTC cough, cold and allergy medicines market has been categorized on the basis of drug type, OTC channel, dosage, and region.
This segmentation analysis is comprehensive, coupled with a detailed country-wise forecast provided on all parameters.
The report’s last section comprises of the global OTC cough, cold and allergy medicines market competitive landscape, to provide readers with the dashboard view of company analysis and market players.
This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global OTC cough, cold and allergy medicines market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients.
Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.